Risk Prediction in Non-Ischemic Cardiomyoapthy

Affiliations

Editorial

Jay A Montgomery et al. J Cardiovasc Electrophysiol. 2025 Jan.

. 2025 Jan;36(1):198-200.

doi: 10.1111/jce.16499. Epub 2024 Nov 19.

¹ Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

No abstract available

References

1. G. H. Bardy, K. L. Lee, D. B. Mark, et al., “Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure,” New England Journal of Medicine 352, no. 3 (2005): 225–237, Erratum in: N Engl J Med. 2005 May 19; 352(20): 2146. PMID: 15659722, https://doi.org/10.1056/NEJMoa043399.
1. A. J. Moss, W. Zareba, W. J. Hall, et al., “Prophylactic Implantation of a Defibrillator in Patients With Myocardial Infarction and Reduced Ejection Fraction,” New England Journal of Medicine 346, no. 12 (2002): 877–883, Epub 2002 Mar 19. PMID: 11907286, https://doi.org/10.1056/NEJMoa013474.
1. A. Kadish, A. Dyer, J. P. Daubert, et al., “Prophylactic Defibrillator Implantation in Patients With Nonischemic Dilated Cardiomyopathy,” New England Journal of Medicine 350, no. 21 (2004): 2151–2158, PMID: 15152060, https://doi.org/10.1056/NEJMoa033088.
1. L. Køber, J. J. Thune, J. C. Nielsen, et al., “Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure,” New England Journal of Medicine 375, no. 13 (2016): 1221–1230. Epub 2016 Aug 27. PMID: 27571011, https://doi.org/10.1056/NEJMoa1608029.
1. A. Yafasova, J. H. Butt, M. B. Elming, et al., “Long‐Term Follow‐Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality),” Circulation 145, no. 6 (2022): 427–436, Epub 2021 Dec 9. PMID: 34882430, https://doi.org/10.1161/CIRCULATIONAHA.121.056072.